Evidence map›Paper›PMID 42682907›Full record

ArticleJournal of arrhythmia2026

Nationwide Lifespan Trends in Cardiac Implantable Electronic Device Strategies in Japan: Age-Dependent Changes in Transvenous and Epicardial Systems.

Aya Miyazaki, Gaku Izumi, Shuhei Fujita, Tsugutoshi Suzuki, Hiroshi Suzuki, Jun Yoshimoto, Keiko Toyohara, Yasunobu Hayabuchi, Masahiko Takagi

Abstract read
In one paragraph

Article in Journal of arrhythmia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aya MiyazakiCIEDs Working Group of Japanese Society of Pediatric Electrocardiology Japan.
Gaku IzumiCIEDs Working Group of Japanese Society of Pediatric Electrocardiology Japan.
Shuhei FujitaCIEDs Working Group of Japanese Society of Pediatric Electrocardiology Japan.
Tsugutoshi SuzukiCIEDs Working Group of Japanese Society of Pediatric Electrocardiology Japan.
Hiroshi SuzukiBoard Member of Japanese Society of Pediatric Electrocardiology Japan.
Jun YoshimotoCardiac Implantable Electronic Device Committee of Japanese Heart Rhythm Society Japan.
Keiko ToyoharaCardiac Implantable Electronic Device Committee of Japanese Heart Rhythm Society Japan.
Yasunobu HayabuchiBoard Member of Japanese Society of Pediatric Electrocardiology Japan.
Masahiko TakagiCardiac Implantable Electronic Device Committee of Japanese Heart Rhythm Society Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Nationwide epidemiological studies of cardiac implantable electronic devices (CIEDs) encompassing multiple device types and strategies remain limited in Japan, particularly regarding epicardial lead use and pediatric populations. Methods: We performed the first nationwide analysis of CIED implantation trends using the National Database of Health Insurance Claims, including transvenous (TV)/epicardial (Epi) systems for pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy (CRT), and CRT-defibrillators (CRTDs), as well as leadless pacemakers, subcutaneous ICDs (S-ICDs), and epicardial lead use. Epicardial lead and pediatric characteristics were supplemented using industry data. Results: In fiscal year 2023, implantation rates per 100 000 population were 29.69 for TV-pacemakers, 7.06 for leadless pacemakers, 2.42 for TV-ICDs, 0.889 for S-ICDs, 1.20 for TV-CRT, and 1.69 for TV-CRTDs. Rates for epicardial systems were lower, at 0.173 for Epi-pacemakers, 0-0.007 for Epi-ICDs, 0.024 for Epi-CRT, and 0.027 for Epi-CRTDs, while epicardial lead use was 0.545. S-ICD use increased across age groups, whereas TV-ICD implantation declined (all Conclusions: CIED strategies in Japan demonstrate age-dependent variation. Epicardial systems remain indispensable in pediatric and congenital heart disease care, whereas alternative technologies are increasingly adopted in older adult populations, reflecting evolving lifespan-related device strategies.

Indexed as

artificial cardiac pacingcardiac resynchronization therapycongenital heart defectsimplantable defibrillatorspediatrics

Identifiers

PMID42682907
PMCPMC13530377

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.